| Active substance |
Toremifene Citrate |
| Also known as |
FC-1157a, Fareston, Toremifene citrate |
| Blood pressure |
Can cause fluctuations in blood pressure |
| Chemical name |
2-{4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy}-N,N-dimethylethanamine |
| Dosage (medical) |
60 mg daily |
| Dosage (sports) |
Not recommended for sports use |
| Effects |
Antiestrogenic, potentially beneficial for breast cancer treatment |
| FORM |
30 tabs x 60 mg |
| Formula |
C26H28ClNO |
| Half-life |
Approximately 5 days |
| Hepatotoxicity |
Low, but liver function tests are recommended |
| Lab Test |
Liver function tests, lipid profile |
| Main action |
Estrogen receptor antagonist |
| Side effects |
Hot flashes, sweating, nausea, dizziness, visual disturbances, thromboembolic events |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Substance class |
Selective Estrogen Receptor Modulator (SERM) |
| Trade name |
Fareston |
| Use in sports |
Mainly used in bodybuilding to mitigate the effects of estrogen due to aromatizable steroids |
| Water Retention |
Minimal |
| Manufacturer |
Orion Corp |
